ReviewCancers2026
Sellar Lesions: Novel Aspects in Diagnosis and Management.
Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modulatory Effects of Bioactive Phytoconstituents on the Amplitude and Gating Properties of Membrane Ion Channels.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this comprehensive review, we explore the evolving landscape of research and clinical practices in sellar lesions, emphasizing recent advancements in histopathology and molecular biology. Distinct lesions can arise from the sellar area, predominantly comprising different tumor types, inflammatory conditions, or systemic conditions. The recent CNS5 World Health Organization classification integrates genetic modifications into histopathological characteristics, enhancing the ability to predict the biological behavior and malignant potential of these lesions. Furthermore, the molecular alterations discovered in these tumors may act as valuable diagnostic and prognostic indicators, facilitating a tailored approach, especially for those demonstrating aggressive characteristics resistant to conventional treatments. The scope of the present review is to provide a comprehensive insight into the current understanding of sellar lesions with regard to emerging prognostic factors, like molecular alterations, to advances in clinical strategies, and to identification of potential new therapeutic targets within the oncology field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.